JP2023529833A5 - - Google Patents

Info

Publication number
JP2023529833A5
JP2023529833A5 JP2022574447A JP2022574447A JP2023529833A5 JP 2023529833 A5 JP2023529833 A5 JP 2023529833A5 JP 2022574447 A JP2022574447 A JP 2022574447A JP 2022574447 A JP2022574447 A JP 2022574447A JP 2023529833 A5 JP2023529833 A5 JP 2023529833A5
Authority
JP
Japan
Prior art keywords
sequence
sequence number
expression construct
artificial expression
composition according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022574447A
Other languages
English (en)
Japanese (ja)
Other versions
JP7767324B2 (ja
JP2023529833A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2021/036028 external-priority patent/WO2021248085A2/en
Publication of JP2023529833A publication Critical patent/JP2023529833A/ja
Publication of JP2023529833A5 publication Critical patent/JP2023529833A5/ja
Priority to JP2025181548A priority Critical patent/JP2026021417A/ja
Application granted granted Critical
Publication of JP7767324B2 publication Critical patent/JP7767324B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022574447A 2020-06-04 2021-06-04 抑制性新皮質ニューロンにおいて遺伝子発現を選択的に調節する人工発現構築物 Active JP7767324B2 (ja)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP2025181548A JP2026021417A (ja) 2020-06-04 2025-10-28 抑制性新皮質ニューロンにおいて遺伝子発現を選択的に調節する人工発現構築物

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063034794P 2020-06-04 2020-06-04
US63/034,794 2020-06-04
PCT/US2021/036028 WO2021248085A2 (en) 2020-06-04 2021-06-04 Artificial expression constructs for selectively modulating gene expression in inhibitory neocortical neurons

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2025181548A Division JP2026021417A (ja) 2020-06-04 2025-10-28 抑制性新皮質ニューロンにおいて遺伝子発現を選択的に調節する人工発現構築物

Publications (3)

Publication Number Publication Date
JP2023529833A JP2023529833A (ja) 2023-07-12
JP2023529833A5 true JP2023529833A5 (https=) 2024-04-23
JP7767324B2 JP7767324B2 (ja) 2025-11-11

Family

ID=78831739

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2022574447A Active JP7767324B2 (ja) 2020-06-04 2021-06-04 抑制性新皮質ニューロンにおいて遺伝子発現を選択的に調節する人工発現構築物
JP2025181548A Pending JP2026021417A (ja) 2020-06-04 2025-10-28 抑制性新皮質ニューロンにおいて遺伝子発現を選択的に調節する人工発現構築物

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2025181548A Pending JP2026021417A (ja) 2020-06-04 2025-10-28 抑制性新皮質ニューロンにおいて遺伝子発現を選択的に調節する人工発現構築物

Country Status (6)

Country Link
US (1) US20230212608A1 (https=)
EP (1) EP4162041A4 (https=)
JP (2) JP7767324B2 (https=)
AU (1) AU2021284465A1 (https=)
CA (1) CA3180017A1 (https=)
WO (1) WO2021248085A2 (https=)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20250142388A (ko) * 2023-02-02 2025-09-30 알렌 인스티튜트 척수 내의 세포에서 유전자 발현을 조정하기 위한 인공 발현 구축물

Family Cites Families (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5399363A (en) 1991-01-25 1995-03-21 Eastman Kodak Company Surface modified anticancer nanoparticles
US5543158A (en) 1993-07-23 1996-08-06 Massachusetts Institute Of Technology Biodegradable injectable nanoparticles
IE80468B1 (en) 1995-04-04 1998-07-29 Elan Corp Plc Controlled release biodegradable nanoparticles containing insulin
AU3642601A (en) * 1999-11-05 2001-05-30 Avigen, Inc. Ecdysone-inducible adeno-associated virus expression vectors
US6812339B1 (en) * 2000-09-08 2004-11-02 Applera Corporation Polymorphisms in known genes associated with human disease, methods of detection and uses thereof
WO2014165753A1 (en) * 2013-04-05 2014-10-09 The Wistar Institute Of Anatomy And Biology Methods and compositions for diagnosis of glioblastoma or a subtype thereof
WO2015191780A2 (en) * 2014-06-10 2015-12-17 The General Hospital Corporation Ccctc-binding factor (ctcf) rna interactome
CA3096407A1 (en) 2018-04-09 2019-10-17 Allen Institute Rescuing voltage-gated sodium channel function in inhibitory neurons
WO2020076614A1 (en) * 2018-10-08 2020-04-16 Allen Institute Artificial expression constructs for selectively modulating gene expression in interneurons
WO2020097121A1 (en) 2018-11-05 2020-05-14 Allen Institute Artificial expression constructs for selectively modulating gene expression in excitatory cortical neurons

Similar Documents

Publication Publication Date Title
JP2026021360A5 (https=)
JP2022513339A5 (https=)
KR102946842B1 (ko) 아데노-연관 바이러스의 조직 향성 변경
US20190315642A1 (en) Compositions for in vivo Expression of Therapeutic Sequences in the Microbiome
CN112040988A (zh) 修饰的aav衣壳多肽用于治疗肌肉疾病
JP2025023947A5 (https=)
ES2685611T3 (es) Vector VAA8 mejorado con una actividad funcional aumentada y métodos de utilización del mismo
TW202106700A (zh) Aav 工程化
US10351452B2 (en) Compositions for in vivo expression of therapeutic sequences in the microbiome
CN109844124A (zh) 年龄相关疾病和病症的基因治疗方法
JP2016533709A (ja) 標的遺伝子治療のための合成コンビナトリアルａａｖカプシドライブラリー
US11883471B2 (en) Enhancing health in mammals using telomerase reverse transcriptase gene therapy
CN113025657A (zh) 一种可用于双模态成像的腺相关病毒及其应用
JP2023518980A5 (https=)
JP2023529833A5 (https=)
WO2004035779A1 (ja) ウイルスエンベロープを用いた生体分子の導入方法ならびにそのための組成物およびシステム
CN111718420A (zh) 一种用于基因治疗的融合蛋白及其应用
JP2024505027A5 (https=)
JP2024519955A5 (https=)
Grinevich et al. Somatic transgenesis (viral vectors)
JP2023535232A (ja) 眼疾患の処置のための組成物および方法
CN113121654A (zh) 新型腺相关病毒衣壳蛋白及包含其的新型腺相关病毒载体
JP7750581B2 (ja) アデノ随伴ウイルスカプシドタンパク質の突然変異体
US20250066437A1 (en) Transgenic expression cassette for treating muscular dystrophy
ES2624659T3 (es) Composiciones terapéuticas de SERCA2 y métodos de uso